Research and Development

The Research and Development team at Egle Therapeutics is dedicated to exploring and developing innovative immunotherapies for cancer and autoimmune diseases. Comprising research scientists, engineers, a bioinformatician, and a target discovery team leader, the team focuses on identifying novel therapeutic targets, conducting preclinical studies, and leveraging advanced bioinformatics tools to accelerate the development of cutting-edge treatment options.